The life cycle of hepatitis B virus and antiviral targets

By Lucifora Julie   Zoulim Fabien  

Future Virology, Vol. 6, Iss. 5, 2011-05 ,pp. : 599-614

Future Medicine

Access to resources Recommend Favorite

Antiviral Natural Products Against Chronic Hepatitis B: Recent Developments

By  

Current Pharmaceutical Design, Vol. 22, Iss. 3, 2016-01 ,pp. : 286-293

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and antiviral activity of N-4'-dihydropyridinyl and dihydroquinolinylcarbonyl-2-hydroxymethyl-5-[cytosin-1'-yl]-1,3-oxathiolane derivatives against human immunodeficiency virus and duck hepatitis B virus

By Camplo M.   Charvet-Faury A.   Borel C.   Turin F.   Hantz O.   Trabaud C.   Niddam V.   Mourier N.   Graciet J.   Chermann J.   Kraus J.  

European Journal of Medicinal Chemistry, Vol. 31, Iss. 7, 1996-01 ,pp. : 539-546

Elsevier

Access to resources Recommend Favorite

Influence of Mutations in the Hepatitis B Virus Genome on Virus Replication and Drug Resistance - Implications for Novel Antiviral Strategies

By  

Current Medicinal Chemistry, Vol. 11, Iss. 20, 2004-10 ,pp. : 2667-2677

Bentham Science Publishers

Access to resources Recommend Favorite

The oral cyclophilin inhibitor DEBIO 025 has a "significant antiviral effect" against different genotypes of the hepatitis C virus

By  

Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite